Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Virogin Biotech

Explore full profile

Virogin Biotech is an antineoplastic drug developer

Richmond, CanadaFounded 2015Biotech & Life Sciences
Valuation $500M–1B Last recorded · 2021
Headcount <100 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Virogin Biotech and the history behind them.

About Virogin Biotech

Virogin.com operates in the digital space, providing essential technical storage and access services. In simpler terms, they offer a platform where users or subscribers can store and access their data securely. This service is particularly useful for individuals or businesses that need to manage large amounts of data or require secure storage for sensitive information.

The company's business model revolves around offering these storage services to subscribers. They generate revenue by charging these subscribers a fee for the storage and access services they provide. This fee is typically based on the amount of storage space used or the level of access required.

Virogin.com operates in a market that is becoming increasingly important as more and more businesses move their operations online and the need for secure, reliable data storage grows. Their clients range from individual users who need to store personal data to large corporations that require secure storage for vast amounts of business data.

One of the key selling points for Virogin.com is their commitment to privacy and security. They state that they only use the stored data for legitimate purposes, such as enabling the use of their service or carrying out the transmission of a communication. They also use the data for statistical purposes, but this is done anonymously to protect the privacy of their users.

In conclusion, Virogin.com is a digital storage service provider that caters to a wide range of clients, from individuals to large corporations. They operate in a growing market and generate revenue by charging for their storage and access services.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2015
Headquarters
Richmond, Canada
Employees
29
Open positions
None listed
Dealroom signal
64.8/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Oncology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
b2b

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES DOther financing Sep 2021 $120M $480M China Life Healthcare Fund ↗
SERIES DOther financing May 2021 $80M $320M GP Capital · Pan-Lin Asset Management · Forebright Capital · China Structural Reform Fund ↗
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

Virogin Biotech website traffic

Latest recorded traffic for Virogin Biotech is 4.3K monthly website visits, up 394.3% over the last three months. Virogin Biotech's team declined 12.1% over the past year.

Latest monthly visits4.3K 3-month web change+394.3% 1-year team growth-12.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

14 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

Series A5 investors entered at this stage

  • GP Capital
  • Fudan University Ningbo Research Institute
  • Sangel Capital
  • Dahua Investment
  • Sinopharm Capital

Series B and later8 investors entered at this stage

  • CDH Investments
  • China Merchants Capital
  • Korea Investment Partners
  • Linden Asset Management
  • Pan-Lin Asset Management
  • Forebright Capital
  • China Structural Reform Fund
  • China Life Healthcare Fund
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇨🇦 Canada57.9%
🇨🇳 China36.8%
🇺🇸 United States5.3%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Virogin Biotech on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Virogin Biotech’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.